in this issue
Regions :: Western Europe :: Germany
Bayer completes acquisition of Teva’s US animal health business
7:29 AM MST | January 4, 2013 | Deepti Ramesh
Bayer HealthCare says it has received the necessary regulatory approval from the FTC to complete the previously announced acquisition of the US-based animal health business of Teva Pharmaceutical Industries (Petaḥ Tiqwa, Israel). The acquisition includes a manufacturing site at St. Joseph, MO, and about 300 employees. Bayer had announced plans for the acquisition in September 2012. Bayer is paying up to $145 million for the acquisition, which includes an upfront payment of $60 million and a total of $85 million in milestone payments, which are linked to the...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee